Pancreatitis clinical trials at UCSF
1 in progress, 0 open to new patients

  • A Randomized Controlled Trial of IV Ketorolac to Prevent Post-ERCP Pancreatitis

    Sorry, not yet accepting patients

    Determine if IV ketorolac is an effective agent in the prevention of post-ERCP pancreatitis. Determine if IV ketorolac provides improved post-procedure analgesia. Determine if systemic mediators of inflammation are reduced in patients receiving IV ketorolac following ERCP.

    San Francisco, California and other locations

© The Regents of the University of California